Post by
Noteable on Nov 25, 2024 6:45pm
OT: Asthma drug "Singular" linked to mental health problems
Launched in 1998, the risk of “serious neuropsychiatric events” including agitation, hostility, depression, anxiousness, insomnia and obsessive-compulsive symptoms in patients who were taking the asthma drug "Singular" were first flagged by the FDA in 2019. Other patients developed suicidal thoughts and behaviors.
https://www.biospace.com/drug-development/mercks-former-asthma-blockbuster-singulair-could-be-linked-to-mental-health-problems-reuters